Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors
- PMID: 9191009
- DOI: 10.1016/s0046-8177(97)90184-2
Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors
Abstract
This study examines the expression of E-cadherin and N-cadherin in the most common epithelial tumors of the ovary. The homotypic interactions of distinctive members of the cadherin family of cell-cell adhesion molecules segregate cells into tissues during embryonic development, and their expression in tumors can be used to trace the histogenesis of tumor cells. Because the surface epithelium of the ovary is a modified mesothelium, we speculated that the expression of E (epithelial)-cadherin and N (neural, mesodermal)-cadherin may provide clues about the controversial origin of common epithelial ovarian tumors. Immunohistochemistry was performed in paraffin sections using well-characterized monoclonal antibodies to E- and N-cadherin and heat-induced antigen-retrieval methods. We found that serous and endometrioid tumors express both E- and N-cadherin. In contrast, mucinous tumors strongly express E-cadherin, but no N-cadherin. The presence of N-cadherin in serous and endometrioid tumors traces their origin to the mesoderm-derived ovarian surface epithelium. The absence of N-cadherin in mucinous tumors clearly distinguishes them from the former, suggesting histogenesis from a cell lineage other than the ovarian surface epithelium or aberrant differentiation mechanisms associated with neoplastic transformation.
Similar articles
-
Inhibitory role of prohibitin in human ovarian epithelial cancer.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2247-55. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966933 Free PMC article.
-
Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.J Histochem Cytochem. 2014 Sep;62(9):619-31. doi: 10.1369/0022155414538821. Epub 2014 May 21. J Histochem Cytochem. 2014. PMID: 24850663
-
Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.J Korean Med Sci. 2006 Feb;21(1):81-5. doi: 10.3346/jkms.2006.21.1.81. J Korean Med Sci. 2006. PMID: 16479070 Free PMC article.
-
Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.Oncology (Williston Park). 2016 Feb;30(2):166-76. Oncology (Williston Park). 2016. PMID: 26892153 Review.
-
Histological classification of ovarian cancer.Med Electron Microsc. 2003 Mar;36(1):9-17. doi: 10.1007/s007950300002. Med Electron Microsc. 2003. PMID: 12658347 Review.
Cited by
-
Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model.Neoplasia. 2005 Oct;7(10):944-56. doi: 10.1593/neo.05358. Neoplasia. 2005. PMID: 16242077 Free PMC article.
-
E-cadherin and cytokeratin subtype profiling in effusion cytology.J Korean Med Sci. 2004 Dec;19(6):826-33. doi: 10.3346/jkms.2004.19.6.826. J Korean Med Sci. 2004. PMID: 15608393 Free PMC article.
-
E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate.Histochem J. 2000 Nov;32(11):659-67. doi: 10.1023/a:1004111331752. Histochem J. 2000. PMID: 11272805
-
Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer.J Histochem Cytochem. 2009 May;57(5):513-21. doi: 10.1369/jhc.2009.953257. Epub 2009 Feb 2. J Histochem Cytochem. 2009. PMID: 19188485 Free PMC article.
-
E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.Proc Natl Acad Sci U S A. 1999 May 25;96(11):6249-54. doi: 10.1073/pnas.96.11.6249. Proc Natl Acad Sci U S A. 1999. PMID: 10339573 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials